Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B

Lianne Fuino, Purva Bali, Sylvie Wittmann, Sreenivasa Donapaty, Fei Guo, Hirohito Yamaguchi, Hong Gang Wang, Peter Atadja, Kapil Bhalla

Research output: Contribution to journalArticlepeer-review

231 Scopus citations

Fingerprint Dive into the research topics of 'Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B'. Together they form a unique fingerprint.

Medicine & Life Sciences